Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
Novo Nordisk, Gilead, BMS and AstraZeneca will feel the most pain from Biden's pricing bill: analysts
Fierce Pharma
Mon, 09/26/22 - 11:25 pm
Inflation Reduction Act
Joe Biden
Novo Nordisk
Gilead Sciences
Bristol Myers Squibb
AstraZeneca
drug pricing
Gilead completes acquisition of MiroBio in $405m cash deal
PM Live
Wed, 09/21/22 - 10:29 am
Gilead Sciences
M&A
MiroBio
autoimmune disease
Gilead's Yescarta eyes first to move up lymphoma ladder in Europe amid busy week at EMA
Fierce Pharma
Mon, 09/19/22 - 09:12 am
Gilead Sciences
Yescarta
Europe
diffuse large B-cell lymphoma
high-grade B-cell lymphoma
ESMO: Gilead's Trodelvy makes surprise comeback with above-par breast cancer survival showing
Fierce Pharma
Wed, 09/7/22 - 11:59 pm
Gilead Sciences
Trodelvy
ESMO
HR-positive HER-negative breast cancer
breast cancer
Brace for an end-of-year boost to drug approvals
EP Vantage
Fri, 09/2/22 - 12:14 pm
FDA
drug approvals
Alnylam Pharmaceuticals
Apellis Pharmaceuticals
Bristol Myers Squibb
Eli Lilly
Gilead Sciences
Mirati Therapeutics
Moderna Therapeutics
Provention Bio
Roche
TG Therapeutics
Travere Therapeutics
Gilead hits back at Bristol Myers' Supreme Court petition in CAR-T patent feud
Fierce Pharma
Sun, 08/28/22 - 10:19 pm
Gilead Sciences
CAR-T
patents
Supreme Court
Kite Pharma
Bristol Myers Squibb
Gilead can't escape antitrust suit centered on pay-for-delay deal with Cipla, judge says
Fierce Pharma
Tue, 08/23/22 - 10:24 pm
Gilead Sciences
Cipla
pay-for-delay
legal generics
Emtriva
Viread
After Trodelvy's approval in China, Gilead strikes $455M deal with Everest for Asian rights
Fierce Pharma
Tue, 08/16/22 - 12:36 pm
Gilead Sciences
Immunomedics
Trodelvy
Everest Medicines
How a small UK biotech ended up in Gilead’s hands
BioPharma Dive
Sun, 08/7/22 - 11:18 pm
Gilead Sciences
MiroBio
M&A
University of Oxford
Gilead Sciences to acquire Oxford University biotech spinout MiroBio for $405M
TechCrunch
Thu, 08/4/22 - 06:41 pm
Gilead Sciences
M&A
University of Oxford
MiroBio
Gilead reports 'very strong quarter' despite slipping Veklury sales
Endpoints
Wed, 08/3/22 - 10:55 am
Gilead Sciences
earnings
Biktarvy
Gilead again backs AlloVir's T cell therapy in $127M direct offering
Endpoints
Wed, 07/27/22 - 10:53 am
Gilead Sciences
AlloVir
funding
t cell therapy
AIDS 2022 preview – Gilead shoots for an HIV cure
EP Vantage
Wed, 07/27/22 - 10:27 am
Gilead Sciences
HIV
AIDS
Pfizer, Gilead and others seek clarifications on trial designs outlined in FDA's UC and Crohn's draft guidance
Endpoints
Thu, 07/21/22 - 10:38 am
Pfizer
Gilead Sciences
Big Pharma
ulcerative colitis
Crohn's Disease
drug development
FDA
Gilead tries again with twice-yearly HIV drug lenacapavir
Pharmaforum
Tue, 06/28/22 - 05:52 pm
Gilead Sciences
HIV
FDA
lenacapavir
Gilead nets $33M in settlement over yearslong HIV drug fraud case in Florida
Fierce Pharma
Tue, 06/28/22 - 10:41 am
Gilead Sciences
HIV
fraud
Florida
legal
Gilead trumpets win for the chronic hepatitis delta prospect it acquired in $1B+ buyout
Fierce Pharma
Thu, 06/23/22 - 07:47 pm
Gilead Sciences
hepatitis delta
Hepcludex
Bristol Myers Squibb takes its CAR-T patent case to US' top court in bid to revive $1.2B verdict against Gilead
Fierce Pharma
Thu, 06/16/22 - 10:48 pm
Bristol Myers Squibb
Gilead Sciences
patents
CAR-T
Juno Therapeutics
ASCO: Gilead's Trodelvy limps forward in new breast cancer lane as below-par showing casts doubt
Fierce Pharma
Sun, 06/5/22 - 11:42 pm
Gilead Sciences
Trodelvy
breast cancer
ASCO 2022
3 cancer drug studies to watch at next month’s ASCO meeting
BioPharma Dive
Thu, 05/26/22 - 10:47 pm
ASCO 2022
AstraZeneca
Enhertu
Gilead Sciences
Trodelvy
Roche
tiragolumab
cancer
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »